The central challenge with many dietary supplements is bioavailability: only a fraction of the ingested amount is actually absorbed by the body. This is precisely where the patent-pending QIDOSHA Bio+ process comes in, enabling up to 15 times greater bioavailability.

This is achieved, firstly, through a carrier system for the active ingredient (e.g., a plant extract such as astaxanthin) with a double membrane made of phospholipids (in the case of lipophilic active ingredients, there is also a fat-soluble core within the double membrane), which is very similar to the human cell structure, and secondly, through a very small particle size of the active ingredient.

The combination of both effects, when taken sublingually, leads to significantly improved bioavailability.